Trial intelligence / Profile preview

Gabapentin Premedication for PONV in Pediatric Adenotonsillectomy

NCT02384187Phase 3Completed

Sponsor
Cairo University
Start
Jan 2015
Primary completion
May 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative nausea and vomiting (PONV) and postoperative pain comparing Placebo with Gabapentin (2 arms). Primary endpoint: Incidence of Postoperative Nausea and Vomiting. Started Jan 2015; status: completed.

02

Drugs

gabapentin
03

Conditions

postoperative nausea and vomiting (PONV)postoperative pain

Beyond the preview

Go deeper on NCT02384187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02384187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call